Symbol
| LTBP2
| contributors: mct/npt - updated : 25-05-2018
|
HGNC name
| latent transforming growth factor beta binding protein 2
|
HGNC id
| 6715
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| germinal mutation
|  
|  
|  
|
in Marfan syndrome | tumoral
|  
|  
| --over
|  
|
in pancreatic ductal adenocarcinoma (PDAC) tissue | |
Susceptibility
|
to BMD variation (bone mineral density) in trochanter and total hip |
Variant & Polymorphism
other
| strong genetic association between LTBP2 gene locus and total hip BMD variation |
|
|
Candidate gene
Marker
| LTBP2 powerfully predicted early pulmonary death (LTBP2 levels were significantly higher in patients dying from pulmonary causes) | |
serum LTBP2 levels might act as a promising biomarker in heart failure with reduced ejection fraction (HFREF) | |
is a novel biomarker for the diagnosis of Pancreatic cancer | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | endocrine | pancreas | |
may be a potential target for PDAC clinical therapy |
| | |